View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
July 18, 2022

Medical Devices industry cross border deals total $3.1bn globally in June 2022

By Carmen

Total Medical devices industry cross border deals worth $3.1bn were announced globally for June 2022, with the $1bn acquisition of MediFox DAN Group being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 305.4% over the previous month of $774.46m and a drop of 15.8% when compared with the last 12-month average of $3.73bn.

In terms of number of cross border deals, the sector saw a rise of 1.69% with 60 deals in June 2022 when compared to the last 12-month average of 59 deals.

In value terms, Europe led the activity with cross border deals worth $2.13bn in June 2022.

Medical devices industry cross border deals in June 2022: Top deals

The top five cross border deals accounted for 73.7% of the overall value during June 2022.

The combined value of the top five cross border deals stood at $2.32bn, against the overall value of $3.1bn recorded for the month.

The top five Medical devices industry cross border deals of June 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $797.86m private equity of SPT Labtech by EQT IX Fund

3) Boston Scientific $230m acquisition deal for 64% stake in M.I.Tech

4) The $177.8m acquisition of Guardant Health AMEA by Guardant Health

5) Alpha Intelligence Capital,CDIB Capital and TCMI $110m venture financing deal with Aidoc Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network